Does STANOZOLOL Cause Focal segmental glomerulosclerosis? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Focal segmental glomerulosclerosis have been filed in association with STANOZOLOL. This represents 6.8% of all adverse event reports for STANOZOLOL.
12
Reports of Focal segmental glomerulosclerosis with STANOZOLOL
6.8%
of all STANOZOLOL reports
0
Deaths
12
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From STANOZOLOL?
Of the 12 reports, 12 (100.0%) required hospitalization, and 4 (33.3%) were considered life-threatening.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for STANOZOLOL. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does STANOZOLOL Cause?
Drug abuse (93)
Intentional product misuse (30)
Left ventricular hypertrophy (26)
Off label use (17)
Acute kidney injury (15)
Testicular atrophy (15)
Acute myocardial infarction (14)
Toxicity to various agents (14)
Hyperthyroidism (13)
Drug-induced liver injury (11)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which STANOZOLOL Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
STANOZOLOL vs STAVUDINE
STANOZOLOL vs STELARA
STANOZOLOL vs STIRIPENTOL
STANOZOLOL vs STIVARGA
STANOZOLOL vs STRATTERA